Glenmark Pharmaceuticals informs about media release

20 Jan 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release on January 20, 2022 titled ‘Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray in for Singapore, Hong Kong and Vietnam.’

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2170.50 1.75 (0.08%)
27-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.65
Dr. Reddys Lab 1281.95
Cipla 1242.65
Zydus Lifesciences 896.60
Lupin 2334.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×